MedPath

DESTINY Breast Respond HER2-low Europe

Recruiting
Conditions
Metastatic Breast Cancer
HER2-low Expressing Breast Cancer
Unresectable Breast Cancer
Interventions
Registration Number
NCT05945732
Lead Sponsor
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Brief Summary

Trastuzumab deruxtecan (T-DXd) as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic HER2-low breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy.

Detailed Description

This non-interventional study will investigate the effectiveness withT-DXd, the demographic and clinical characteristics of the patients, treatment patterns, tolerability, management of adverse drug reactions (ADRs), and patient experience of T-DXd in patients with HER2-low unresectable and/or metastatic breast cancer. Patients will be treated according to the proposed indication statement in the Summary of Product Characteristics (SmPC). No drug product will be administered as part of this study.

Data on conventional chemotherapy (i.e., including but not limited to capecitabine, eribulin, gemcitabine, paclitaxel and nab-paclitaxel) will also be collected in a disease registry part of the study.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1350
Inclusion Criteria
  • Adult patient (age ≥ 18 years) with histological or cytological confirmed diagnosis of unresectable and/or mBC
  • Documented HER2-low status (IHC1+, IHC2+/ISH-)
  • Patients who have received prior chemotherapy in the metastatic setting or patients who have developed disease recurrence during or within 6 months of completing adjuvant chemotherapy
  • Decision to newly initiate therapy of T-DXd or conventional chemotherapy according to the physicians choice per SmPC
  • Written and signed Informed Consent to participate in the study
Exclusion Criteria
  • Pregnancy or breastfeeding
  • Patients who at time of data collection for this study are participating in or have participated in an interventional study that remains blinded.

No specific exclusion criteria are defined, as patients will be treated according to the proposed indication statements in the SmPC.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Trastuzumab deruxtecan (T-DXd)Trastuzumab deruxtecanParticipants with HER2-low expressing unresectable and/or metastatic breast cancer who will be treated with trastuzumab deruxtecan and part of the enrolled participants will receive conventional chemotherapy. The participants on conventional chemotherapy will be analyzed exploratory only.
Primary Outcome Measures
NameTimeMethod
Real World Time to Next Treatment (rwTTNT1) in Participants With HER2-low Expressing Unresectable and/or Metastatic Breast CancerBaseline up to 31 months
Secondary Outcome Measures
NameTimeMethod
Type of Treatment Patterns in Participants With HER2-low Expressing Unresectable and/or Metastatic Breast CancerBaseline up to 31 months
Real World Time to Permanent Treatment Discontinuation (rwTTD1) in Participants With HER2-low Expressing Unresectable and/or Metastatic Breast CancerBaseline up to 31 months
Number of Physician-reported Safety Events of Interest in Participants With HER2-low Expressing Unresectable and/or Metastatic Breast Cancer (T-DXd only)Baseline up to 31 months
Number of Participants Receiving Prophylactic and Reactive Treatment Management for Physician-reported Safety Events of Interest in Participants With HER2-low Expressing Unresectable and/or Metastatic Breast Cancer (T-DXd only)Baseline up to 31 months
Patient's Global Impression of Treatment Tolerability (PGI-TT) in Participants With HER2-low Expressing Unresectable and/or Metastatic Breast CancerBaseline up to 31 months

The PGI-TT is designed to assess the treatment tolerability of the medicine. Participants will rate the bother associated with any treatment-related symptoms based on a 5-point scale ranging from 1 (not at all) to 5 (very much). Higher scores indicate a worse outcome.

European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) Score in Participants With HER2-low Expressing Unresectable and/or Metastatic Breast CancerBaseline up to 31 months

The EORTC QLQ-C30 questionnaire is designed to measure cancer patients' physical, psychological and social functions. The EORTC QLQ-C30 scales and single-item scales range in score from 0 to 100. A higher score for the functioning scales and global health status denotes a better level of functioning (i.e. a better state of the patient), while higher scores on the symptom and single-item scales indicate a higher level of symptoms (i.e. a worse state of the patient).

Number of Participants Reporting Nausea and Vomiting as Assessed by a Patient DiaryBaseline up to 31 months

Trial Locations

Locations (197)

CH Cote Basque

🇫🇷

Bayonne, France

Hospital Universitario Ramón y Cajal

🇪🇸

Madrid, Spain

Hospital Clínico Universitario San Carlos

🇪🇸

Madrid, Spain

Hospital Universitario 12 de Octubre

🇪🇸

Madrid, Spain

Hospital de Getafe

🇪🇸

Madrid, Spain

Hospital Virgen Arrixaca de Murcia

🇪🇸

Murcia, Spain

Hospital Universitario Central de Asturias

🇪🇸

Oviedo, Spain

Complejo Asistencial Universitario de Palencia

🇪🇸

Palencia, Spain

Hospital Son Espases

🇪🇸

Palma de Mallorca, Spain

Hospital Son Llatzer

🇪🇸

Palma, Spain

Hospital de Pontevedra

🇪🇸

Pontevedra, Spain

Hospital San Joan de Reus

🇪🇸

Reus, Spain

Hospital Universitari Parc Taulí

🇪🇸

Sabadell, Spain

Hospital General de Catalunya

🇪🇸

Sant Cugat del Vallès, Spain

Onkologikliniken Mälarsjukhuset

🇸🇪

Eskilstuna, Sweden

Hospital Universitario Marqués de Valdecilla

🇪🇸

Santander, Spain

Hospital Universitario General de Valencia

🇪🇸

Valencia, Spain

Hospital Clínico de Valladolid

🇪🇸

Valladolid, Spain

Hospital Universitario Rio Hortega

🇪🇸

Valladolid, Spain

Bröstcentrum, Karolinska Universitetssjukhuset Solna

🇸🇪

Stockholm, Sweden

Complejo Hospitalario Universitario De Vigo

🇪🇸

Vigo Pontevedra, Spain

Gävle Hospital

🇸🇪

Gävle, Sweden

Ryhov County Hospital

🇸🇪

Jönköping, Sweden

Capio St Görans sjukhus

🇸🇪

Stockholm, Sweden

Onkologkliniken Sundsvalls Sjukhus

🇸🇪

Sundsvall, Sweden

Department of Oncology, Västerås

🇸🇪

Västerås, Sweden

Department of Oncology, Örebro University Hospital

🇸🇪

Örebro, Sweden

Kantonsspital Baden

🇨🇭

Baden, Switzerland

Spital Thurgau AG - Kantonsspital Frauenfeld

🇨🇭

Frauenfeld, Switzerland

Centre du sein Fribourg

🇨🇭

Fribourg, Switzerland

Clinique Generale-Beaulieu / Clinique de Genolier

🇨🇭

Genève, Switzerland

Réseau Hospitalier Neuchâtelois (RHNe)

🇨🇭

La Chaux-de-Fonds, Switzerland

Réseau du Sein Lausanne

🇨🇭

Lausanne, Switzerland

CHUV

🇨🇭

Lausanne, Switzerland

Kantonsspital Baselland

🇨🇭

Liestal, Switzerland

Hôpital du Valais Sion

🇨🇭

Sion, Switzerland

Kantonsspital St.Gallen

🇨🇭

St. Gallen, Switzerland

ZIO AG

🇨🇭

Zürich, Switzerland

Universitätsspital Zürich

🇨🇭

Zürich, Switzerland

Medizinische Universität Graz

🇦🇹

Graz, Austria

Hôpital Privé d'Antony

🇫🇷

Antony, France

Hôpital Privé les Bonnettes

🇫🇷

Arras, France

CHU de Limoges

🇫🇷

Limoges, France

Hôpital Jean Mermoz

🇫🇷

Lyon, France

Centre Hospitalier de Pau

🇫🇷

Pau, France

Centre Eugene Marquis

🇫🇷

Rennes, France

Centre d'oncologie Saint-Yves

🇫🇷

Vannes, France

Hospital Universitario de Cruces

🇪🇸

Barakaldo, Spain

Hospital de la Santa Creu i Sant Pau

🇪🇸

Barcelona, Spain

Cancercentrum, Norrlands Universitetssjukhus

🇸🇪

Umeå, Sweden

Landesklinikum Wiener Neustadt

🇦🇹

Wiener Neustadt, Austria

Clinique de l'Europe

🇫🇷

Amiens, France

Institut du Cancer Avignon Provence

🇫🇷

Avignon, France

Medizinische Universität Innsbruck

🇦🇹

Innsbruck, Austria

Klinikum Klagenfurt am Wörthersee

🇦🇹

Klagenfurt am Wörthersee, Austria

LKH Hochsteiermark-Leoben

🇦🇹

Leoben, Austria

Ordensklinikum Linz GmbH Barmherzige Schwestern

🇦🇹

Linz, Austria

Interne II, LKH Feldkirch

🇦🇹

Rankweil, Austria

KH der Barmherzigen Brüder Salzburg

🇦🇹

Salzburg, Austria

Uniklinikum Salzburg

🇦🇹

Salzburg, Austria

Salzkammergut Klinikum Vöcklabruck

🇦🇹

Vöcklabruck, Austria

Klinikum Wels-Grieskirchen GmbH

🇦🇹

Wels, Austria

Medical University of Vienna

🇦🇹

Wien, Austria

Medizinische Universität Wien

🇦🇹

Wien, Austria

Krankenhaus Hietzing

🇦🇹

Wien, Austria

ASZ Aalst

🇧🇪

Aalst, Belgium

Chirec Delta Hospital

🇧🇪

Auderghem, Belgium

Imeldaziekenhuis Bonheiden

🇧🇪

Bonheiden, Belgium

AZ Klina

🇧🇪

Brasschaat, Belgium

AZ Sint-Jan Brugge av

🇧🇪

Brugge, Belgium

CHU Brugmann

🇧🇪

Brussels, Belgium

Cliniques universitaires Saint-Luc

🇧🇪

Brussels, Belgium

Chu Helora- Hôpital de La Louvière- site Jolimont

🇧🇪

Haine Saint Paul, Belgium

Jessa Ziekenhuis

🇧🇪

Hasselt, Belgium

CHU Tivoli

🇧🇪

La Louviere, Belgium

Hôpital de la Citadelle

🇧🇪

Liege, Belgium

CHC MontLegia

🇧🇪

Liège, Belgium

CHU UCL Namur/Site Sainte Elisabeth

🇧🇪

Namur, Belgium

Clinique Saint Pierre Ottignies

🇧🇪

Ottignies, Belgium

VITAZ

🇧🇪

Sint-Niklaas, Belgium

CHR Verviers East Belgium

🇧🇪

Verviers, Belgium

Aalborg Universitetshospital, Syd

🇩🇰

Aalborg, Denmark

Aarhus University Hospital

🇩🇰

Aarhus N, Denmark

Herlev Hospital

🇩🇰

Herlev, Denmark

Onkologisk og Palliativ afdeling, Nordsjællands Hospital

🇩🇰

Hillerød, Denmark

Naestved Hospital

🇩🇰

Naestved, Denmark

Sygehus Sønderjylland, Sønderborg

🇩🇰

Sønderborg, Denmark

CHU Amiens Picardie

🇫🇷

Amiens, France

Centre Francois Baclesse

🇫🇷

Caen, France

Pole Sante Leonard De Vinci

🇫🇷

Chambray-lès-Tours, France

Clinique Belharra

🇫🇷

Bayonne, France

Chu Jean Minjoz Besancon

🇫🇷

Besançon, France

Clinique Tivoli-Ducos

🇫🇷

Bordeaux, France

Centre Léonard de Vinci

🇫🇷

Dechy, France

Centre hospitalier Fleyriat

🇫🇷

Bourg-en-Bresse, France

CH Metropole Savoie

🇫🇷

Chambéry, France

CH Cholet

🇫🇷

Cholet, France

Hôpital Henri Mondor

🇫🇷

Créteil, France

Centre Hospitalier William Morey

🇫🇷

Chalon-sur-Saône, France

Centre Jean Perrin

🇫🇷

Clermont-Ferrand, France

Polyclinique St Côme

🇫🇷

Compiègne, France

CHU Martinique

🇫🇷

Fort De France Cedex, France

Centre Georges Francois Leclerc

🇫🇷

Dijon, France

CHI Frejus Saint Raphael

🇫🇷

Fréjus, France

Groupe Hospitalier Mutualiste (GHM) de Grenoble - Institut Daniel Hollard (IDH)

🇫🇷

Grenoble, France

Polyclinique De Blois

🇫🇷

La Chaussee Saint Victor, France

La Tronche - CHU Grenoble

🇫🇷

La Tronche, France

Centre de cancerologie de la Sarthe

🇫🇷

Le Mans, France

Centre Hospitalier Emile Roux

🇫🇷

Le Puy-en-Velay, France

Hôpital Franco-Britannique Cognac Jay

🇫🇷

Levallois-Perret, France

Centre Oscar Lambret

🇫🇷

Lille, France

CHU Lille

🇫🇷

Lille, France

Hôpital Prive Le Bois

🇫🇷

Lille, France

Hospices Civils De Lyon

🇫🇷

Lyon, France

Hôpital-Clinique Claude Bernard

🇫🇷

Metz, France

GH Havre

🇫🇷

Montivilliers, France

Clinique Clementville

🇫🇷

Montpellier, France

Groupe Hospitalier privé Ambroise Pare Hartmann

🇫🇷

Neuilly-sur-Seine, France

Hopital Americain de Paris

🇫🇷

Neuilly-sur-Seine, France

Centre Antoine Lacassagne

🇫🇷

Nice, France

Centre Hospitalier de Niort

🇫🇷

Niort, France

Centre Médical ONCOGARD

🇫🇷

NÎMES Cedex 9, France

Institut Curie

🇫🇷

Paris, France

Groupement Hospitalier Diaconesses Croix Saint Simon

🇫🇷

Paris, France

Hopital Europeen Georges Pompidou

🇫🇷

Paris, France

Hôpital Saint Joseph

🇫🇷

Paris, France

CHU Poitiers

🇫🇷

Poitiers, France

Institut Godinot

🇫🇷

Reims, France

Polyclinique Courlancy

🇫🇷

Reims, France

Clinique Saint Hilaire

🇫🇷

Rouen, France

Clinique Mathilde

🇫🇷

Rouen, France

Saint Cloud -Rene Huguenin Institut Curie

🇫🇷

Saint-Cloud, France

CHU Réunion Site Sud

🇫🇷

Saint-Paul, France

Institut De Cancerologie Paris Nord

🇫🇷

Sarcelles, France

Centre Hospitalier de Sens

🇫🇷

Sens Cédex, France

Hôpital Foch

🇫🇷

Suresnes, France

CHR Metz Thionville

🇫🇷

Thionville, France

HIA Sainte-Anne

🇫🇷

Toulon, France

Centre Hospitalier de Troyes

🇫🇷

Troyes, France

Hopital Prive Drome Ardeche

🇫🇷

Valence, France

Nouvelle Clinique Des Dentellières

🇫🇷

Valenciennes, France

Institut De Cancerologie De Lorraine

🇫🇷

Vandœuvre-lès-Nancy, France

Médipôle Hôpital Mutualiste

🇫🇷

Villeurbanne, France

Azienda Ospedaliera di Alessandria

🇮🇹

Alessandria, Italy

Ospedale SS Annunziata

🇮🇹

Chieti, Italy

Ospedale Citta' di Castello USL Umbria 1

🇮🇹

Città di Castello, Italy

Ospedale San Giuseppe - Azienda USL Toscana Centro

🇮🇹

Empoli, Italy

ASL Lecce - Ospedale "Vito Fazzi"

🇮🇹

Lecce, Italy

ASST Lecco - PO "Alessandro Manzoni"

🇮🇹

Lecco, Italy

AULSS 9 Scaligera - Ospedale Mater Salutis

🇮🇹

Legnago, Italy

ASST Ovest Milanese - Ospedale di Legnano

🇮🇹

Legnano, Italy

Ospedale Generale Provinciale di Macerata

🇮🇹

Macerata, Italy

Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST IRCCS

🇮🇹

Meldola, Italy

AOU di Modena

🇮🇹

Modena, Italy

Fondazione IRCCS San Gerardo dei Tintori

🇮🇹

Monza, Italy

AOU Federico II

🇮🇹

Napoli, Italy

AOU Maggiore della Carità di Novara

🇮🇹

Novara, Italy

IOV - Istituto Oncologico Veneto - IRCCS

🇮🇹

Padova, Italy

La Maddalena S.p.A.

🇮🇹

Palermo, Italy

ARNAS Ospedale Civico e Benfratelli

🇮🇹

Palermo, Italy

Fondazione IRCCS Policlinico San Matteo

🇮🇹

Pavia, Italy

AOU Pisana - Stabilimento Santa Chiara

🇮🇹

Pisa, Italy

AO Regionale San Carlo

🇮🇹

Potenza, Italy

GOM "BMM" - Presidio Ospedaliero Morelli

🇮🇹

Reggio Calabria, Italy

Azienda USL IRCCS di Reggio Emilia

🇮🇹

Reggio Emilia, Italy

ASL RM 2 Ospedale Pertini

🇮🇹

Roma, Italy

AO San Giovanni Addolorata

🇮🇹

Roma, Italy

AOU "San Giovanni di Dio e Ruggi d'Aragona"

🇮🇹

Salerno, Italy

IRCCS Ospedale Casa Sollievo della Sofferenza

🇮🇹

San Giovanni Rotondo, Italy

AOU Sassari - Ospedale Civile SS. Annunziata

🇮🇹

Sassari, Italy

Ospedale San Vincenzo

🇮🇹

Taormina, Italy

AOU Città della Salute e della Scienza di Torino - Ospedale Molinette

🇮🇹

Torino, Italy

AO Ordine Mauriziano

🇮🇹

Torino, Italy

AULSS n. 2 Marca trevigiana - Ospedale "Cà Foncello"

🇮🇹

Treviso, Italy

ASUFC Udine - Santa Maria della Misericordia

🇮🇹

Udine, Italy

Drammen Sykehus

🇳🇴

Drammen, Norway

ASST Sette Laghi "Ospedale di Circolo e Fondazione Macchi "

🇮🇹

Varese, Italy

Nordlandssjukhuset Bodø

🇳🇴

Bodø, Norway

Sørlandet sykehus / Kristiansand Hospital

🇳🇴

Kristiansand, Norway

Universitetssjukhuset Nord-Norge

🇳🇴

Tromsø, Norway

Hospital Universitario de Basurto

🇪🇸

Bilbao, Spain

Hospital Universitario Reina Sofia

🇪🇸

Cordoba, Spain

Hospital Universitario San Pedro de Alcántara

🇪🇸

Cáceres, Spain

Sykehuset Telemark

🇳🇴

Skien, Norway

Hospital Clinico Universitario de Albacete

🇪🇸

Albacete, Spain

Hospital Universitario de Puerto Real

🇪🇸

Cádiz, Spain

Hospital Universitario de La Ribera

🇪🇸

Alzira, Spain

Hospital General Universitario de Elche

🇪🇸

Elche, Spain

Hospital Clinico Universitario de Granada (PTS)

🇪🇸

Granada, Spain

Hospital de Galdakao

🇪🇸

Galdakao, Spain

Hospital Universitario Médico-Quirúrgico de Jaén

🇪🇸

Jaén, Spain

Hospital Universitario de Canarias

🇪🇸

La Laguna, Spain

Complejo Asistencial Universitario de León

🇪🇸

León, Spain

Hospital Universitario San Pedro de Logroño

🇪🇸

Logroño, Spain

Hospital Universitario Lucus Augusti

🇪🇸

Lugo, Spain

Hospital Universitario la Princesa

🇪🇸

Madrid, Spain

Hospital MD Anderson Cancer Center

🇪🇸

Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath